Equitable Holdings’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
60,279
+8,181
| +16% | +$314K | 0.02% | 526 |
|
|
2025
Q1 | $2.02M | Buy |
52,098
+4,178
| +9% | +$162K | 0.02% | 509 |
|
|
2024
Q4 | $1.62M | Sell |
47,920
-554
| -1% | -$18.7K | 0.02% | 534 |
|
|
2024
Q3 | $1.98M | Buy |
48,474
+4,036
| +9% | +$165K | 0.02% | 493 |
|
|
2024
Q2 | $1.71M | Buy |
44,438
+3,371
| +8% | +$130K | 0.02% | 505 |
|
|
2024
Q1 | $1.76M | Sell |
41,067
-4,158
| -9% | -$178K | 0.02% | 480 |
|
|
2023
Q4 | $1.68M | Sell |
45,225
-92
| -0.2% | -$3.41K | 0.02% | 457 |
|
|
2023
Q3 | $1.64M | Buy |
45,317
+5,026
| +12% | +$182K | 0.02% | 420 |
|
|
2023
Q2 | $1.44M | Buy |
40,291
+4,647
| +13% | +$166K | 0.02% | 425 |
|
|
2023
Q1 | $1.27M | Buy |
35,644
+3,563
| +11% | +$127K | 0.02% | 418 |
|
|
2022
Q4 | $1.13M | Buy |
32,081
+5,379
| +20% | +$189K | 0.02% | 419 |
|
|
2022
Q3 | $786K | Buy |
26,702
+5,167
| +24% | +$152K | 0.02% | 448 |
|
|
2022
Q2 | $1.17M | Buy |
21,535
+334
| +2% | +$18.2K | 0.02% | 376 |
|
|
2022
Q1 | $1.15M | Buy |
21,201
+1,183
| +6% | +$64.4K | 0.02% | 380 |
|
|
2021
Q4 | $1.1M | Buy |
20,018
+2,789
| +16% | +$154K | 0.02% | 378 |
|
|
2021
Q3 | $823K | Buy |
17,229
+131
| +0.8% | +$6.26K | 0.01% | 423 |
|
|
2021
Q2 | $851K | Buy |
17,098
+2,699
| +19% | +$134K | 0.01% | 413 |
|
|
2021
Q1 | $642K | Buy |
14,399
+798
| +6% | +$35.6K | 0.01% | 449 |
|
|
2020
Q4 | $626K | Buy |
13,601
+2,250
| +20% | +$104K | 0.01% | 410 |
|
|
2020
Q3 | $534K | Sell |
11,351
-175
| -2% | -$8.23K | 0.01% | 402 |
|
|
2020
Q2 | $588K | Buy |
11,526
+790
| +7% | +$40.3K | 0.02% | 377 |
|
|
2020
Q1 | $508K | Buy |
10,736
+6,301
| +142% | +$298K | 0.02% | 363 |
|
|
2019
Q4 | $261K | Buy |
+4,435
| New | +$261K | 0.01% | 528 |
|